HIGHLIGHTS
- who: Low-Grade Gliomas and colleagues from the Department of Neurosurgery, National Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China have published the paper: Development and Validation of a Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Low-Grade Gliomas, in the Journal: Disease Markers of 23/09/2022
- what: In the present study, to confirm the hypothesis , the authors developed an LLPS-related gene signature independent of known features to identify high-risk LGG.
SUMMARY
Low-grade gliomas (LGGs) account for 10-20% of all primary . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.